Discovery Tools (Healthcare) · Seattle, WA · Founded 2020 · Privately Held (backing)
Developer of cell therapies designed to improve the safety and efficacy of gene therapies. Outpace Bio is based in Seattle, WA and was founded in 2020. Its last known valuation is $220 million. It has raised $199 million across 1 recorded round; the latest was a $144 million Series B in Jul 2024.
Last price · $/share
—
Implied valuation
$220.0M
Total raised
$199.0M
Last round
Early Stage VC (Series B)
Jul 2024
Team — not yet on record
No current team members for Outpace Bio are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Outpace Bio with a free account
·The complete investor list: 20 names
·Watch Outpace Bio: the Monday email on marks, rounds and moves
